Related Experiment Video
Updated: Aug 19, 2026
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Immunohistochemical expression of matrix metalloproteinases in bile duct cancer tissue
1Department of Surgery, Kurume University School of Medicine, Kurume 830-0011, Japan. takenori1966@r4.dion.ne.jp
Abstract:
In the present study we have examined the immunohistochemical expression of matrix metalloproteinases (MMPs) in bile duct cancer tissue and the relationship between MMP expression and various clinicopathologic factors. We performed immunohistochemical studies of matrix metalloproteinase-2 (MMP2), and matrix metalloproteinase-3 (MMP3). MMP2 and MMP3 were expressed in 48.9% (23/47) and 44.7% (21/47) of the subjects, respectively. Subjects positive for MMP2 showed significantly higher association rates of MMP3 expression than those who were not (p<0.05). MMP2 expression was also significantly higher in the group with histologically well-differentiated lesions than in the group with poorly differentiated lesions (p<0.05). Expression of MM2 and MM3 was significantly higher in subjects with neural invasion (p<0.05). The MMP2-negative group had a significantly better prognosis than the MMP2-positive group (p<0.05). MMP2 expression tended to increase as the degree of differentiation decreased, and this indicated a possibility that MMP2 and MMP3 may be involved in the development of perineural invasion in bile duct cancer. Perineural invasion is an important prognostic factor in bile duct cancer, and the fact that various types of cytokines are involved in the activation of MMPs suggested that bile duct cancer complicated by obstructive cholangitis might be associated with a poorer prognosis.
Insights
Matrix metalloproteinase-2 (MMP2) and MMP3 expression in bile duct cancer correlates with poorer differentiation and neural invasion. MMP2-positive patients showed a worse prognosis, suggesting MMPs role in cancer progression.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Bile duct cancer (cholangiocarcinoma) is an aggressive malignancy with limited treatment options.
- Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix degradation and have been implicated in cancer progression.
- Understanding the role of specific MMPs in bile duct cancer is crucial for identifying prognostic markers and therapeutic targets.
Purpose of the Study:
- To investigate the immunohistochemical expression of matrix metalloproteinase-2 (MMP2) and matrix metalloproteinase-3 (MMP3) in bile duct cancer tissues.
- To analyze the correlation between MMP2 and MMP3 expression and clinicopathological factors, including tumor differentiation and neural invasion.
- To evaluate the prognostic significance of MMP2 expression in patients with bile duct cancer.
Main Methods:
- Immunohistochemical analysis was performed on 47 bile duct cancer tissue samples to detect MMP2 and MMP3 expression.
- Statistical analysis was used to assess the relationship between MMP expression and clinicopathological variables such as tumor differentiation, neural invasion, and patient prognosis.
Main Results:
- MMP2 and MMP3 were expressed in 48.9% and 44.7% of bile duct cancer tissues, respectively.
- MMP2 expression was significantly associated with poorer histological differentiation (p<0.05) and the presence of neural invasion (p<0.05).
- Patients with MMP2-negative tumors exhibited a significantly better prognosis compared to those with MMP2-positive tumors (p<0.05).
Conclusions:
- MMP2 and MMP3 expression is prevalent in bile duct cancer and is linked to aggressive tumor features.
- MMP2 expression serves as a potential negative prognostic biomarker in bile duct cancer.
- These findings suggest that MMP2 and MMP3 may play a role in the development of perineural invasion and overall tumor progression in bile duct cancer.
